News & Updates

Senate committee unveils ambitious plan to cap drug price hikes, out-of-pocket expenses

Stat News By LEV FACHER and NICHOLAS FLORKO JULY 23, 2019 WASHINGTON — A key Senate committee on Tuesday unveiled a long-awaited package of drug pricing reforms that would cap how much drug makers can hike their prices in Medicare. It would also cap out-of-pocket expenses for Medicare beneficiaries and dramatically reform the program’s prescription drug benefit.The bipartisan effort, read more…

Generic drugs ‘wildly overpriced’ in Medicare, study finds

Becker’s Hospital Review Morgan Haefner – Monday, July 15th, 2019 Many generic drugs in Medicare Part D are “wildly overpriced,” according to an analysis from drug pricing research firm 46brooklyn. The report, which examined data from CMS’ Prescription Drug Plan Formulary, Pharmacy Network, and Pricing Information Files, found that while some generic drugs are priced fairly, others “show unbelievable read more…

National LTC Pharmacy Advocacy Group Asks CMS to Release “Summary Data” on PBM Medicare Spread Pricing Activity

SCPC Thanks CMS for Curtailing PBM Medicaid Spread Pricing; Time for Similar Medicare Transparency…Read More.

‘An Arm And A Leg’: Why Are Drug Prices So Random? Meet Mr. PBM

Kaiser Health News
Surely, an old-time, generic drug can’t cost $720 — for a three-month supply…Read More.

As CMS Mitigates Medicaid ‘Spread Pricing’ Abuse, Time to Address Medicare Abuses

Morning Consult
Under the leadership of Centers for Medicare and Medicaid Services Administrator Seema Verma, the Trump administration recently released key guidance mitigating pharmacy benefit managers’ abusive “spread pricing” practices in state Medicaid-managed care programs…Read More.

As CMS Curtails PBM “Spread Pricing” in Medicaid, SCPC Says Similar Medicare Abuses Require Scrutiny and Transparent Data Release

National Long Term Care (LTC) Pharmacy Group Urges CMS to Release Medicare
Spread Pricing “Summary” Data…Read More.

Drug plan middle men under scrutiny

Boston Globe
They are the secret middlemen in the chain of rising prescription drug costs…Read More.

Drug middlemen name own prices, methodology goes unchallenged

The Columbus Dispatch
Ohio Medicaid officials and their managed-care contractors say they’re bringing new transparency to an opaque drug-delivery system that in 2017 saw more than a quarter-billion-dollar markup to taxpayers…Read More.

National LTC Pharmacy Advocacy Group Praises HELP Discussion Draft Bill, Offers Comments on Drug Pricing and PBM Transparency Recommendations

Senior Care Pharmacy Coalition (SCPC), Citing Unique Nature of Elderly Patient Population, Makes Case To Include Statutory Definition of Long-Term Care Pharmacy in Draft Legislation…Read More.

Two more big states take aim at PBM pricing practices, which one lawmaker calls ‘the wild west’

The controversial role that pharmacy benefit managers play in prescription drug pricing is under fresh attack in a pair of new reports issued by two of the largest state…Read More.

Twitter   LinkedIn